| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 7, 2026 | ±2.5% | -0.6% | over-priced |
| November 7, 2025 | ±2.4% | +3.2% | under-priced |
| August 6, 2025 | ±3.8% | -0.1% | over-priced |
| May 6, 2025 | ±3.6% | -1.2% | over-priced |
| November 5, 2024 | ±3.4% | +1.3% | over-priced |
| August 5, 2024 | ±5.2% | -1.9% | over-priced |
| May 10, 2024 | ±2.5% | +0.1% | over-priced |
| November 7, 2023 | ±4.2% | -3.3% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.64 | $872M | $133M |
| Q4 FY2025 | $1.56 | $877M | $295M |
| Q3 FY2025 | $-0.77 | $872M | $-117M |
| Q2 FY2025 | $0.56 | $868M | $119M |
BXP, Inc. (BXP) reports in 100 days, with the next report estimated for September 21, 2026. Across the last 8 reports, options priced an average ±3.4% earnings move while the stock actually moved 1.5% on average — the market has systematically over-priced BXP's earnings risk. Fundamentals into the print: EPS up 64.1% year-over-year, revenue up 0.8%. QuantLogix's live 5-factor engine currently reads BXP as a buy at 57/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →